Literature DB >> 34964866

5. Facilitating Behavior Change and Well-being to Improve Health Outcomes: Standards of Medical Care in Diabetes-2022.

Boris Draznin, Vanita R Aroda, George Bakris, Gretchen Benson, Florence M Brown, RaShaye Freeman, Jennifer Green, Elbert Huang, Diana Isaacs, Scott Kahan, Jose Leon, Sarah K Lyons, Anne L Peters, Priya Prahalad, Jane E B Reusch, Deborah Young-Hyman.   

Abstract

The American Diabetes Association (ADA) "Standards of Medical Care in Diabetes" includes the ADA's current clinical practice recommendations and is intended to provide the components of diabetes care, general treatment goals and guidelines, and tools to evaluate quality of care. Members of the ADA Professional Practice Committee, a multidisciplinary expert committee (https://doi.org/10.2337/dc22-SPPC), are responsible for updating the Standards of Care annually, or more frequently as warranted. For a detailed description of ADA standards, statements, and reports, as well as the evidence-grading system for ADA's clinical practice recommendations, please refer to the Standards of Care Introduction (https://doi.org/10.2337/dc22-SINT). Readers who wish to comment on the Standards of Care are invited to do so at professional.diabetes.org/SOC.
© 2021 by the American Diabetes Association.

Entities:  

Mesh:

Year:  2022        PMID: 34964866     DOI: 10.2337/dc22-S005

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  23 in total

Review 1.  Advancements and future directions in the teamwork, targets, technology, and tight control-the 4T study: improving clinical outcomes in newly diagnosed pediatric type 1 diabetes.

Authors:  Dessi P Zaharieva; Franziska K Bishop; David M Maahs
Journal:  Curr Opin Pediatr       Date:  2022-08-01       Impact factor: 2.893

Review 2.  The patient-centered diabetes management during the COVID-19 pandemic.

Authors:  Noriko Kodani; Mitsuru Ohsugi
Journal:  Glob Health Med       Date:  2022-08-31

Review 3.  Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD).

Authors:  Melanie J Davies; Vanita R Aroda; Billy S Collins; Robert A Gabbay; Jennifer Green; Nisa M Maruthur; Sylvia E Rosas; Stefano Del Prato; Chantal Mathieu; Geltrude Mingrone; Peter Rossing; Tsvetalina Tankova; Apostolos Tsapas; John B Buse
Journal:  Diabetologia       Date:  2022-09-24       Impact factor: 10.460

4.  Preventing, Screening, and Treating Suicidality in Pediatric Type 1 Diabetes: Roles for Behavioral Health Care Professionals.

Authors:  Sarah S Jaser; Marisa E Hilliard
Journal:  Diabetes Care       Date:  2022-05-01       Impact factor: 17.152

5.  Maintaining Physical Activity Is Associated with Reduced Major Adverse Cardiovascular Events in People Newly Diagnosed with Diabetes.

Authors:  Duhoe Kim; Jaehun Seo; Kyoung Hwa Ha; Dae Jung Kim
Journal:  J Obes Metab Syndr       Date:  2022-05-27

Review 6.  Diabetes: the role of continuous glucose monitoring.

Authors:  Julianna Rivich Kluemper; Alexandria Smith; Brooke Wobeter
Journal:  Drugs Context       Date:  2022-06-14

Review 7.  Diabetes: how to manage cardiovascular risk in secondary prevention patients.

Authors:  Sarah L Anderson; Joel C Marrs
Journal:  Drugs Context       Date:  2022-06-14

Review 8.  Is Time-Restricted Eating Safe in the Treatment of Type 2 Diabetes?-A Review of Intervention Studies.

Authors:  Sarah Uldal; Kim Katrine Bjerring Clemmensen; Frederik Persson; Kristine Færch; Jonas Salling Quist
Journal:  Nutrients       Date:  2022-05-30       Impact factor: 6.706

Review 9.  Comorbidity of Type 2 Diabetes Mellitus and Depression: Clinical Evidence and Rationale for the Exacerbation of Cardiovascular Disease.

Authors:  Mengmeng Zhu; Yiwen Li; Binyu Luo; Jing Cui; Yanfei Liu; Yue Liu
Journal:  Front Cardiovasc Med       Date:  2022-03-10

10.  Implementation of diabetes care and educational program via telemedicine in patients with COVID-19 in home isolation in Thailand: A real-worldexperience.

Authors:  Tasma Harindhanavudhi; Chatvara Areevut; Taninee Sahakitrungruang; Thipaporn Tharavanij; Pongtorn Kietdumrongwong; Orasa Ngimruksa; Patitta Songsiri; Siwadon Pitukweerakul; Nattamon Tanathornkirati; Natthapon Kaewprasert; Ruchirek Thamcharoen; Krittadhee Karndumri; Sunee Saetung; Pimjai Anthanont; Pornpimol Kiattisakthavee; Sarapee Putkong; Phawinpon Chotwanvirat; Chorthip Nartsupha Phattanasri; Srikorn Jinadit; Sira Korpaisarn; Manusvinee Chusane; Rattanapan Samittarucksa; Amornpan Lertrit; Sanguansak Siangruangsang; Kanokporn Sanpawithayakul; Waraporn Sathiravikarn; Sataporn Soisuwan; Parawee Chevaisrakul; Kanokporn Imsakul; Pinradakarn Thuptimtong; Jandanee Sakmanarit; Supaporn Somwang; Hussamon Prasartkaew; Ratanaporn Jerawatana; Siriwan Butadej; Porntip Tachanivate; Wallaya Jongjaroenprasert; Jeeraphan Sripatong; Sunanta Chobtangsilp; Pattraphorn Kamnirdsittiseree; Benjaporn Savetkairop; Warot Manosittisak; Jitra Tantivatanasatien; Amornrat Hathaidechadusadee; Sirimon Reutrakul
Journal:  J Diabetes Investig       Date:  2022-04-25       Impact factor: 3.681

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.